discovered that Venetoclax can enhance DN T cell-mediated cytotoxicity against AML cells by increasing reactive oxygen species generation and subsequently increasing NKG2D and DNAM-1 expression in DN T cells. Here, CD226 is linked to acute myeloid leukemia.